• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

威斯康星糖尿病视网膜病变流行病学研究。第六部分:视网膜光凝术。

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation.

作者信息

Klein R, Klein B E, Moss S E, Davis M D, DeMets D L

机构信息

Department of Ophthalmology, University of Wisconsin Medical School, Madison 53792.

出版信息

Ophthalmology. 1987 Jul;94(7):747-53. doi: 10.1016/s0161-6420(87)33525-0.

DOI:10.1016/s0161-6420(87)33525-0
PMID:3658346
Abstract

The prevalence of focal and panretinal photocoagulation and its relationship to demographic and other characteristics were examined in a population-based study in southern Wisconsin. For participants whose age at diagnosis was less than 30 years and who were taking insulin (996 persons) the prevalence rate of panretinal photocoagulation (13.9%) was higher than that of focal photocoagulation (3.6%). For those whose age at diagnosis was 30 years or older (1370 persons), the prevalence rate for panretinal photocoagulation (3.6%) was slightly higher than that of focal photocoagulation (3.0%). Seventy-two percent of eyes of younger onset and 45% of eyes of older onset persons that had received panretinal photocoagulation treatment were found to have incomplete regression of retinal new vessels, and in approximately half of these eyes severe proliferative retinopathy (Diabetic Retinopathy Study High Risk Characteristics [DRS-HRC]) was present. Among eyes with DRS-HRC, 55% were found to be untreated.

摘要

在威斯康星州南部的一项基于人群的研究中,对局部和全视网膜光凝的患病率及其与人口统计学和其他特征的关系进行了检查。对于诊断时年龄小于30岁且正在使用胰岛素的参与者(996人),全视网膜光凝的患病率(13.9%)高于局部光凝(3.6%)。对于诊断时年龄为30岁或以上的参与者(1370人),全视网膜光凝的患病率(3.6%)略高于局部光凝(3.0%)。在接受全视网膜光凝治疗的年轻发病者的眼中,72%发现视网膜新生血管未完全消退,在这些眼中约一半存在严重的增殖性视网膜病变(糖尿病视网膜病变研究高危特征[DRS-HRC])。在患有DRS-HRC的眼中,55%未接受治疗。

相似文献

1
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation.威斯康星糖尿病视网膜病变流行病学研究。第六部分:视网膜光凝术。
Ophthalmology. 1987 Jul;94(7):747-53. doi: 10.1016/s0161-6420(87)33525-0.
2
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: VIII. The incidence of retinal photocoagulation.
J Diabet Complications. 1988 Apr-Jun;2(2):79-87. doi: 10.1016/0891-6632(88)90008-6.
3
Fluorometric evaluation of panretinal photocoagulation in diabetic subjects.糖尿病患者全视网膜光凝的荧光评估
Acta Ophthalmol Scand. 1997 Aug;75(4):393-7. doi: 10.1111/j.1600-0420.1997.tb00396.x.
4
One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变全视网膜光凝的一年期转归
Am J Ophthalmol. 2000 Feb;129(2):178-85. doi: 10.1016/s0002-9394(99)00322-0.
5
Quantitation of retinal ablation in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变中视网膜消融的定量分析。
Am J Ophthalmol. 1995 Jun;119(6):760-6. doi: 10.1016/s0002-9394(14)72782-5.
6
Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.一项随机临床试验中,对比扩展靶向视网膜光凝与传统全视网膜光凝治疗增殖性糖尿病视网膜病变的疗效
Int Ophthalmol. 2018 Feb;38(1):313-321. doi: 10.1007/s10792-017-0469-7. Epub 2017 Feb 6.
7
Long-term Effect of Panretinal Photocoagulation on Spectral Domain Optical Coherence Tomography Measurements in Diabetic Retinopathy.全视网膜光凝对糖尿病视网膜病变光谱域光学相干断层扫描测量的长期影响
Curr Eye Res. 2017 Aug;42(8):1169-1173. doi: 10.1080/02713683.2017.1280510. Epub 2017 Mar 24.
8
[Panretinal photocoagulation with or without focal photocoagulation--the effect on central retinal thickness].全视网膜光凝联合或不联合局灶性光凝——对视网膜中央厚度的影响
Oftalmologia. 2010;54(2):99-103.
9
[Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].[2型糖尿病并发症糖尿病性视网膜病变患者的激光光凝治疗结果]
Klin Oczna. 2006;108(1-3):66-9.
10
[Results of panretinal photocoagulation in preproliferative and proliferative ischemic diabetic retinopathy: apropos of 235 eyes followed for 6 months to 8 years].
Bull Soc Ophtalmol Fr. 1986 Nov;86(11):1363-6.

引用本文的文献

1
Comparison of conbercept and ranibizumab for the treatment efficacy of diabetic macular edema: a Meta-analysis and systematic review.康柏西普与雷珠单抗治疗糖尿病性黄斑水肿疗效的比较:一项Meta分析与系统评价
Int J Ophthalmol. 2019 Sep 18;12(9):1479-1486. doi: 10.18240/ijo.2019.09.17. eCollection 2019.
2
Cost-effectiveness of Different Diabetic Retinopathy Screening Modalities.不同糖尿病视网膜病变筛查方式的成本效益
J Diabetes Sci Technol. 2015 Dec 29;10(2):301-7. doi: 10.1177/1932296815624109.
3
Are individuals with diabetes seeing better?: a long-term epidemiological perspective.
糖尿病患者的视力是否有所改善?:长期流行病学视角
Diabetes. 2010 Aug;59(8):1853-60. doi: 10.2337/db09-1904.
4
Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis.安大略省詹姆斯湾地区糖尿病视网膜病变筛查:一项成本效益分析。
CMAJ. 2003 Jan 21;168(2):160-4.
5
Cost savings associated with detection and treatment of diabetic eye disease.与糖尿病眼病检测和治疗相关的成本节约。
Pharmacoeconomics. 1995;8 Suppl 1:33-9. doi: 10.2165/00019053-199500081-00008.
6
Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice.2型糖尿病并发症的筛查、预防、咨询及治疗。将证据应用于实践。
J Gen Intern Med. 1997 Sep;12(9):567-80. doi: 10.1046/j.1525-1497.1997.07111.x.